Folic acid cuts congential heart defects 6%

1 June 2009

A new study conducted by Canadian researchers shows that folic acid also decreases the incidence of congenital heart defects by more than 6%.

Since December 1998, all grain products sold in Canada have been  fortified with folic acid with 0.15mg of folate per 100g of flour.  Thanks to provincial databases, the researchers showed that the rate of  congenital heart defects between 1999 and 2005 was 1.47 per 1,000  births compared to 1.64 per 1,000 births between 1990 and 1999 for a  decrease of 6.2% per year after 1999.

Researchers are constantly assessing the beneficial effects of folic  acid on the various aspects of embryonic and infant development. Natural  sources of the vitamin, such as fruit or green vegetables, might not  provide sufficient doses for pregnant women. Most gynecologists  therefore recommend supplements in addition to a healthy diet rich in  folic acid.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight